Related Experiment Video
Updated: Dec 25, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas
Daisuke Matsubara1,2, Taichiro Yoshimoto1, Manabu Soda3
1Division of Integrative Pathology, Jichi Medical University, Shimotsuke, Japan.
Abstract:
Molecular targeted therapies against EGFR and ALK have improved the quality of life of lung adenocarcinoma patients. However, targetable driver mutations are mainly found in thyroid transcription factor-1 (TTF-1)/NK2 homeobox 1 (NKX2-1)-positive terminal respiratory unit (TRU) types and rarely in non-TRU types. To elucidate the molecular characteristics of the major subtypes of non-TRU-type adenocarcinomas, we analyzed 19 lung adenocarcinoma cell lines (11 TRU types and 8 non-TRU types). A characteristic of non-TRU-type cell lines was the strong expression of TFF-1 (trefoil factor-1), a gastric mucosal protective factor. An immunohistochemical analysis of 238 primary lung adenocarcinomas resected at Jichi Medical University Hospital revealed that TFF-1 was positive in 31 cases (13%). Expression of TFF-1 was frequently detected in invasive mucinous (14/15, 93%), enteric (2/2, 100%), and colloid (1/1, 100%) adenocarcinomas, less frequent in acinar (5/24, 21%), papillary (7/120, 6%), and solid (2/43, 5%) adenocarcinomas, and negative in micropapillary (0/1, 0%), lepidic (0/23, 0%), and microinvasive adenocarcinomas or adenocarcinoma in situ (0/9, 0%). Expression of TFF-1 correlated with the expression of HNF4-α and MUC5AC (P < .0001, P < .0001, respectively) and inversely correlated with that of TTF-1/NKX2-1 (P < .0001). These results indicate that TFF-1 is characteristically expressed in non-TRU-type adenocarcinomas with gastrointestinal features. The TFF-1-positive cases harbored KRAS mutations at a high frequency, but no EGFR or ALK mutations. Expression of TFF-1 correlated with tumor spread through air spaces, and a poor prognosis in advanced stages. Moreover, the knockdown of TFF-1 inhibited cell proliferation and soft-agar colony formation and induced apoptosis in a TFF-1-high and KRAS-mutated lung adenocarcinoma cell line. These results indicate that TFF-1 is not only a biomarker, but also a potential molecular target for non-TRU-type lung adenocarcinomas.
Insights
Trefoil factor-1 (TFF-1) is highly expressed in non-terminal respiratory unit (non-TRU) lung adenocarcinomas, correlating with KRAS mutations and poor prognosis. TFF-1 shows potential as a biomarker and therapeutic target for these lung cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Targeted therapies for EGFR and ALK mutations have benefited lung adenocarcinoma patients.
- Targetable mutations are primarily found in TTF-1/NKX2-1-positive terminal respiratory unit (TRU) types, not non-TRU types.
- Understanding non-TRU subtypes is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To elucidate the molecular characteristics of major non-TRU-type lung adenocarcinoma subtypes.
- To investigate the role of trefoil factor-1 (TFF-1) in non-TRU lung adenocarcinomas.
- To assess TFF-1 as a potential biomarker and therapeutic target.
Main Methods:
- Analyzed 19 lung adenocarcinoma cell lines (11 TRU, 8 non-TRU).
- Performed immunohistochemical analysis of TFF-1 in 238 primary lung adenocarcinomas.
- Correlated TFF-1 expression with other markers (HNF4-α, MUC5AC, TTF-1/NKX2-1) and mutations (EGFR, ALK, KRAS).
- Investigated TFF-1's effect on cell proliferation, colony formation, and apoptosis via knockdown experiments.
Main Results:
- TFF-1 was strongly expressed in non-TRU-type cell lines and detected in 13% of primary lung adenocarcinomas.
- TFF-1 expression was frequent in mucinous, enteric, and colloid subtypes, inversely correlated with TTF-1/NKX2-1, and correlated with HNF4-α and MUC5AC.
- TFF-1-positive cases showed high KRAS mutation frequency, lacked EGFR/ALK mutations, correlated with tumor spread, and indicated poor prognosis in advanced stages.
- TFF-1 knockdown inhibited proliferation and colony formation, and induced apoptosis in a TFF-1-high, KRAS-mutated cell line.
Conclusions:
- TFF-1 is characteristically expressed in non-TRU-type lung adenocarcinomas with gastrointestinal features.
- TFF-1 serves as a potential biomarker for KRAS-mutated lung adenocarcinomas and predicts poor prognosis.
- TFF-1 represents a potential molecular target for non-TRU-type lung adenocarcinomas.
Related Concept Videos
General Transcription Factors
Transcription Factors
TGF - β Signaling Pathway
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
lncRNA - Long Non-coding RNAs
Co-activators and Co-repressors

